Who We Are

PhysIQ is laser focused on providing solutions that meet strict FDA requirements — all while pioneering the power of the IoT and expanding our transformational proprietary analytics.

Dan Malven


Dan Malven is a Managing Director of 4490 Ventures, a leading early-stage venture capital firm. Dan’s background is a blend of venture capital investing, startup operational and corporate executive experience. Dan was the founding CEO of Analyte Health, a digital health company, an executive in the consumer health services group of Walgreens, and a co-founder of two software technology companies. Dan has invested in approximately 20 early-stage startups over his career. Four of those investments exited via IPO, with those companies possessing an aggregated current public market capitalization of approximately $10 billion, and several others have exited via acquisition. Dan has a Masters of Business Administration from the Kellogg School of Management at Northwestern University and a Bachelor of Science in Industrial Engineering from Purdue University. Dan is an alumni of the Kauffman Fellows Program and a member of YPO.

Contact us and transform the future of real-world patient insight.

At physIQ, we welcome the opportunity to speak with potential customers, partners or anyone with an interest in learning more about the transformative potential of our technology.

Contact Us